Floatz logo

Therapeutic Asset Ratings

780 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[18f]psma-1007
Oncology
AHS Cancer Control AlbertaP2CCC (53)
[18f]psma-1007
Prostate Neoplasm
Primo Biotechnology Co., LtdP2CCC (53)
[18f]rccb6
Kidney Neoplasms
RenJi HospitalP2CCC (53)
[18f]rccb6
Urogenital Neoplasms
RenJi HospitalP2CCC (53)
[18f]rccb6
Urologic Neoplasms
RenJi HospitalP2CCC (53)
[68ga]cbp8
Interstitial Lung Disease
Peter CaravanP2CCC (53)
[68ga]cbp8
Radiation Fibrosis
Massachusetts General HospitalP2CCC (53)
[68ga]cbp8
Radiation Induced Lung Injury
Massachusetts General HospitalP2CCC (53)
[68ga]ga-nota-r8b4
Lymphoma, Large B-Cell, Diffuse
RenJi HospitalP2CCC (53)
[68ga]ga-nota-r8b4
Nasopharyngeal Carcinoma
RenJi HospitalP2CCC (53)
[68ga]ga-nota-r8b4
Renal Cancer
RenJi HospitalP2CCC (53)
[68ga]ga-nota-r8b4
Renal Clear Cell Carcinoma
RenJi HospitalP2CCC (53)
[68ga]ga-nota-rd06
Lymphoma, Large B-Cell, Diffuse
RenJi HospitalP2CCC (53)
[68ga]ga-nota-rd06
Nasopharyngeal Carcinoma
RenJi HospitalP2CCC (53)
[68ga]ga-nota-rd06
Renal Cancer
RenJi HospitalP2CCC (53)
[68ga]ga-nota-rd06
Renal Clear Cell Carcinoma
RenJi HospitalP2CCC (53)
68ga-psma
Malignant Melanoma
Royal Marsden NHS Foundation TrustP2CCC (53)
[99mtc]tc-db8
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of SciencesP2CCC (53)
Flotufolastat F-18
Prostate
University of FloridaP2CCC (53)
Fluciclovine
Glioblastoma, IDH-Wildtype
ECOG-ACRIN Cancer Research GroupP2CCC (53)
Fpi-2265
Metastatic Castration Resistant Prostate Cancer
Fusion Pharmaceuticals Inc.P2CCC (53)
Gallium-68 Labelled Fap-2286
Breast Cancer Detection
Odense University HospitalP2CCC (53)
rad101
Brain Metastases From Solid Tumors
Radiopharm Theranostics, LtdP2CCC (53)
Yttrium-90
Radioembolization
Derek W. CoolP2CCC (53)
Yttrium-90
Renal Cell Carcinoma (RCC)
Derek W. CoolP2CCC (53)
Showing 76 to 100 of 780 assets
PreviousPage 4 of 32Next